Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.99 USD | +0.67% | +5.15% | -2.28% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 606M |
---|---|---|---|---|---|
Net income 2024 * | -114M | Net income 2025 * | -139M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.22
x | P/E ratio 2025 * |
-4.66
x | Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.45% |
Latest transcript on ORIC Pharmaceuticals, Inc.
1 day | +0.67% | ||
1 week | +5.15% | ||
1 month | +1.81% | ||
3 months | -29.43% | ||
6 months | +13.80% | ||
Current year | -2.28% |
Managers | Title | Age | Since |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 18-05-06 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Director of Finance/CFO | 50 | 19-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 21-11-08 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Mardi Dier
BRD | Director/Board Member | 60 | 20-03-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.48% | 4 M€ | -5.15% | - | |
0.03% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 8.99 | +0.67% | 973,865 |
24-05-30 | 8.93 | +5.68% | 457,108 |
24-05-29 | 8.45 | -4.09% | 345,742 |
24-05-28 | 8.81 | +3.04% | 322,057 |
24-05-24 | 8.55 | -2.84% | 638,729 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.28% | 606M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ORIC Stock